Entity Details
| Primary name |
ASPG_HUMAN |
| Entity type |
UniProt |
| Source |
Source Link |
Details
| Accession | P20933 |
| EntryName | ASPG_HUMAN |
| FullName | N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase |
| TaxID | 9606 |
| Evidence | evidence at protein level |
| Length | 346 |
| SequenceStatus | complete |
| DateCreated | 1991-02-01 |
| DateModified | 2021-06-02 |
Subcellular Location
Show/Hide Table
| Subcellular Location |
| Lysosome |
Domains
Show/Hide Table
| Domain | Name | Category | Type |
| IPR000246 | Peptidase T2, asparaginase 2 | Family | Family |
| IPR029055 | Nucleophile aminohydrolases, N-terminal | Family | Homologous superfamily |
Diseases
Show/Hide Table
| Disease ID | Source | Name | Description |
| 208400 | OMIM | Aspartylglucosaminuria (AGU) | An inborn lysosomal storage disease causing excess accumulation of glycoasparagine in the body tissues and its increased excretion in urine. Clinical features include mild to severe mental retardation manifesting from the age of two, coarse facial features and mild connective tissue abnormalities. The disease is caused by variants affecting the gene represented in this entry. |
Interactions
6 interactions